Industries:
Biotechnology
Investor Types:
Venture Capital
Investment Stages:
Late Stage Venture
Early Stage Venture
Location: Italy
Their mission is to identify innovative research in life science and to develop novel therapies and tools by creating successful business initiatives in a sustained and long term way.
Genextra`s holding structure is designed to increase the probability of success of business initiatives that become part of the Group by providing specialist
management as well as financial support to a new company vehicle or an existing young start-up.
Genextra was created in 2004 by a group of prominent Italian entrepreneurs and financial institutions in partnership with leading scientists from the European Institute of Oncology (IEO).
To date, Genextra has raised over €116 million and represents one of very few examples in Italy of private capital invested for the benefit of research and innovation.